High-resolution MHC haplotyping update coincides with Twist Bioscience stock consolidating near highs

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience down 0.85% today

Highlights

TWST maintains a strong bullish trend, currently trading above key short-, medium-, and long-term technical support levels.
Momentum signals are predominantly positive, but several oscillators indicate short-term overbought conditions and possible consolidation.
The expected trading range for the coming week is $66.00–$73.00, with a high probability of upside retest unless support at $66.00 breaks.

A link to the medRxiv preprint was included. Details are being clarified.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish trend confirmed as price holds above key averages

TWST is trading at $68.63, well above the MA-20 ($60.82), MA-50 ($57.26), and MA-200 ($40.93). This positioning confirms a strong bullish trend across short, medium, and long-term horizons. The Ichimoku Kijun on D1 is $64.27, which is below the current price, making it an immediate support. Near-term support lies at the Ichimoku Kijun ($64.27), with key support at the MA-50 ($57.26). Immediate resistance is at the MA-5/EMA-5 area ($70.13–$70.70), with key resistance at the recent range high near $80.50.

Buyer momentum persists despite overbought signals and weekly retreat

Momentum on D1 is positive, with both MACD and ADX signaling continued strength from buyers. RSI is elevated at 61.88, with CCI also bullish, while Stoch RSI issues a strong sell, highlighting short-term overbought pressure and a potential pause. BBP signals overbought conditions but with underlying buyer dominance. Awesome Oscillator remains in favor of further gains. Over the past week, TWST has slipped $0.59 (0.72%) from a prev_week_close of $69.22, currently testing the very bottom of its weekly range. Weekly volatility stands at 20.26%. The setup reflects a steady decline from recent highs after strong upside, with mixed oscillators hinting at profit-taking or a pause in upside momentum.

Upward bias likely as consolidation holds near top of yearly range

Looking ahead, the expected trading range for the coming week is $66.00–$73.00, anchoring price action closer to the top end of the yearly range—far above the 52-week low of $23.30 yet within reach of the $80.50 high. Based on W1 signals from MA-50, MACD, ADX, and RSI, there is a very high probability (more than 80%) of a renewed upward move, while downside risk is less likely. The baseline scenario sees consolidation between $66.00 and $73.00. A bullish scenario would target a break above $73.00, opening potential for another test of the yearly high, while a bearish outcome could see a breakdown below $66.00 toward the $64.00 support cluster, though sustained selling appears unlikely without further momentum reversal.

Earlier, analysts noted that Twist Bioscience was benefiting from strong bullish momentum and constructive technical signals, while cautioning that near-term overbought conditions could lead to volatility. In light of unfolding developments, investors should closely monitor for any emerging trends or shifts in momentum that could influence the prevailing outlook for TWST.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.